ACCELERATED TECHNOLOGIES PARTNERS
Accelerated Technologies Partners (รขโฌลATPรขโฌย) is an investment partnership that focuses on medical devices and actively leverages a structured collaboration between world-leading physicians, experienced operational management and dedicated capital to produce superior returns and substantial clinical value. By aligning the interests and harnessing the collective resources of physicians, management and investors from inception through exit, the ATP strategy supports the acceleration of product development and lowers market and execution risks, enhancing capital efficiency and improving the likelihood of outstanding returns.
ACCELERATED TECHNOLOGIES PARTNERS
Industry:
Finance Medical Device Venture Capital
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Nginx PHP New Relic Apache 2.2 Debian DNS.COM
Similar Organizations
Myca Partners
Myca Partners is an investment vehicle focusing on small-cap public markets.
Signal Equity Partners
Signal Equity Partners is an investment partnership focused on the communications, media, and technology sectors.
VantEdge Partners
VantEdge Partners is a private investment group that focuses on building partnerships.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2009-03-23 | Claros Diagnostics | Accelerated Technologies Partners investment in Series B - Claros Diagnostics | 4 M USD |
| 2007-01-19 | Claros Diagnostics | Accelerated Technologies Partners investment in Series A - Claros Diagnostics | 7.8 M USD |
| 2006-06-30 | Mitralign | Accelerated Technologies Partners investment in Series B - Mitralign | 13 M USD |
| 2005-06-08 | Mitralign | Accelerated Technologies Partners investment in Venture Round - Mitralign | 6.7 M USD |
| 2004-05-10 | Mitralign | Accelerated Technologies Partners investment in Series A - Mitralign | 3.5 M USD |
| 2003-01-01 | Impella Cardiosystems | Accelerated Technologies Partners investment in Venture Round - Impella Cardiosystems | 40 M USD |